logo/base Created with Sketch.

Guided VCTE™

Seamless liver health assessment for all


Faster examinations with improved guidance1

Two new visual indicators allow operators to quickly identify the optimal measurement location. Computed by a continuous vibration of the probe transducer, these indicators intuitively guide the operator throughout the entire duration of the exam.

With Guided VCTE™, 96% of patients can be scanned in less than 4 minutes, including patients with BMI>30.

Simplified scanning for a strengthened user experience

Based on the Guided VCTE™ indicators, AutoScan automatically triggers 10 valid measurements through a single click, enabling streamlined scanning and a likely improved operator experience.

Guided VCTE™ includes all SmartExam features

  • Improved reliability in the diagnosis and monitoring of steatosis
    with Continuous CAP™ to decrease variability by 50%2


  • Extended usage among patients with severe obesity with deeper assessment of liver fibrosis and steatosis as the maximum probe-to-capsula distance is increased by 28%*


  • Automated features such as CAP™ validity criteria and automatic measurement depth selection to adapt to patient’s morphology

Guided VCTETM is endorsed by healthcare professionals


The addition of Guided VCTE™ is practice changing as it provides benefits to the provider and operator. Our clinical practice is able to be more efficient with the combination of a faster scan, providing my operators with easier localization and consistent measurements. The new reports contain a more refined image facilitating my interpretations. Guided VCTE™ has augmented both our comfort and confidence in measurement accuracy when diagnosing our patients with liver disease.

Tejas Joshi | Hepatologist, Director of Liver Diseases & Associate Professor | Marshall University School of Medicine


Guided VCTE™ technology has significantly improved the operator’s confidence that the probe is in the right place over the liver, excluding either lung or rib artifact. This will also enhance reliability when performing sequential scans on the same patient.

Martin Grajower | MD, FACP, FACE | Endocrinologist, Clinical Professor of Medicine | Albert Einstein College of Medicine

chevron chevron

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459) and are manufactured by Echosens™. These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies. This marketing material is not intended for US audience. © 2024 Echosens – Echosens™ and FibroScan® are trademarks owned by Echosens SA. All rights reserved.

The Guided VCTE™ technology is only available on the latest FibroScan® systems and can be used only with M+ and XL+ probes.

* Without SmartExam, the maximum recommended Probe-to-Capsula distance (PCD) is 35 mm. With SmartExam, it is 45mm, representing an increase of 28%.

1. Based on internal data. E431R020.1.
2. E. Bardou-Jacquet et al. Validation of the Continuous Controlled Attenuation Parameter (CAPc) using the MRI-PDFF as reference. EASL 2022 poster #FRI-228.